Molecular basis of drug recognition by specific T-cell receptors

International Archives of Allergy and Immunology

Volumn 119, Issue 3, 1999, Pages 173-180

  Von Greyerz, Salome ^a   Burkhart, Christoph ^a   Pichler, Werner J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Allergy; Antigen presentation; Drug; Non peptide antigens; T cells

Indexed keywords

ANTICONVULSIVE AGENT; BETA LACTAM ANTIBIOTIC; LIDOCAINE; LOCAL ANESTHETIC AGENT; PENICILLIN G; SULFONAMIDE; T LYMPHOCYTE RECEPTOR;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; DRUG HYPERSENSITIVITY; DRUG RECEPTOR BINDING; HEMOLYTIC ANEMIA; HEPATITIS; HUMAN; NEPHRITIS; PRIORITY JOURNAL; RASH; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; URTICARIA;

EID: 0032812965     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024192     Document Type: Review

References (49)

1. I. Porcelli SA, Morita CT, Modlin RL: T-cell recognition of non-peptide antigens. Curr Opin Immunol 1996;8:510-516.
2. Sieling PA, Chetterjee D, Porcelli SA, Prigozy TI, Soriano T, Brenner MB, Kronenberg M, Brennan PJ, Modlin RL: CD1 restricted T cell recognition of microbial lipoglycans. Science 1995;269:227-230.
3. Grant EP, Degano M, Rosat JP, Stenger S, Modlin RL, Wilson IA, Porcelli SA, Brenner MB: Molecular recognition of lipid antigens by T cell receptors. J Exp Med 1999;189: 195-205.
4. Corinti S, de Palma R, Fontana A, Gagliardi C, Pini C, Sallusto F: Major histocompatibility complex-independent recognition of a distinct pollen antigen, most likely a carbohydrate by human CD8+ αβ T cells. J Exp Med 1997;186: 899-908.
5. Zanni MP, Schnyder B, von Greyerz S, Pichler WJ: Involvement of T cells in drug-induced allergies. Trends Pharmacol Sci 1998;19:308-310.
6. Weltzien HU, Moulin C, Martin S, Padovan E, Hartmann U, Kohler J: T cell immune response to haptens: Structural models for allergic and autoimmune reactions. Toxicology 1996;107: 141-151.
7. Hoigné R, Schlumberger HU, Vervleot D, Zoppi M: Epidemiology of allergic drug reactions; in Burr ML (ed): Epidemiology of Allergic Diseases. Monogr Allergy. Basel, Karger, 1993, vol 31, pp 140-170.
8. Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ: Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulphonamides, phenytoin and carbamazepine. J Immunol 1995;155:462-472.
9. Pichler WJ, Schnyder B, Zanni M, Hari Y, von Greyerz S: Role of T cells in drug allergies. Allergy 1998;53:225-232.
10. Hertl M, Merk HF: Lymphocyte activation in cutaneous drug reactions. J Invest Dermatol 1995;105:95-98.
11. Zanni MP, Mauri-Hellweg D, Brander C, Wendland T, Schnyder B, Frei E, von Greyerz S, Bircher A, Pichler WJ: Characterization of lidocaine specific T cells. J Immunol 1997; 158:1139-1148.
12. von Greyerz S, Zanni MP, Frutig K, Schnyder B, Burkhart C, Pichler WJ: Interaction of sulphonamide derivatives with the TCR of sulphamethoxazole-specific human ab+ T cell clones. J Immunol 1999;162:595-602.
13. Pichler WJ, Zanni M, von Greyerz S, Schnyder B, Mauri-Hellweg D, Wendland T: High IL-5 production by drug specific T cell clones. Int Arch Appl Allergy Immunol 1997;113:177-180.
14. Brander C, Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, Pichler WJ: Heterogeneous T cell responses to β-lactam-modified self-structures are observed in penicillin-allergic individuals. J Immunol 1995;155:2670-2678.
15. Dent LA, Strath M, Mellor AL, Anderson CJ: Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990;172:1425-1432.
16. Hertl M, Geisel J, Boecker C, Merk HF: Selective generation of CD8+ T cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibiotics. Br J Dermatol 1993;128:619-626.
17. Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ: Direct, MHC-dependent presentation of the drug sulphamethoxazole to human αβ T cell clones. J Clin Invest 1997; 100:136-141.
18. Schnyder B, Frutig K, Mauri-Hellweg D, Limat A, Yawalkhar N, Pichler WJ: T cell mediated cytotoxicity against keratinocytes in sulphamethoxazole-induced skin reaction. Clin Exp Allergy 1998;28:1412-1417.
19. Padovan E, Bauer T, Tongia MM, Kalbacher H, Weltzien HU: Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 1997;27: 1303-1307.
20. Schneider CH, de Weck AL: Chemische Aspekte der Penicillin-Allergie: Die direkte Penicilloylierung von ε-Aminogruppen durch Penicilline bei pH 7.4. Helv Chem Acta 1966; 49:1695-1699.
21. Naisbitt DJ, Hough SJ, Gill HJ, Pirmohamed M, Kitteringham NR, Park BK: Conjugation of sulphamethoxazole to protein and human white blood cells: Possible role in toxicity and protection by reductases. Br J Pharmacol 1999;126:1393-1407.
22. Weltzien HU, Padovan E: Molecular features of penicillin allergy. J Invest Dermatol 1998; 110:203-206.
23. Padovan E, von Greyerz S, Pichler WJ, Weltzien HU: Antigen-dependent and -independent IFN-γ modulation by penicillins. J Immunol 1999;162:1171-1177.
24. Park BK, Pirmohamed M, Kitteringham NR: Role of drug disposition in drug hypersensitivity: A chemical, molecular, and clinical perspective. Chem Res Toxicol 1998;11:969-988.
25. Zanni MP, von Greyerz S, Schnyder B, Wendland T, Pichler WJ: Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific αβ+ T cell clones. Int Immunol 1998; 10:507-515.
26. Zanni MP, von Greyerz S, Schnyder B, Brander KA, Frutig K, Hari Y, Valitutti S, Pichler WJ: HLA-restricted, processing-and metabolism-independent pathway of drug recognition by human ab T lymphocytes. J Clin Invest 1998;102:1591-1598.
27. Valitutti S, Müller S, Cella M, Padovan E, Lanzavecchia A: Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995;375:148-151.
28. Valitutti S, Lanzavecchia A: Serial triggering of TCRs: A basis for the sensitivity and specificity of antigen recognition. Immunol Today 1997;18:299-304.
29. Zanni MP, von Greyerz S, Hari Y, Schnyder B, Pichler WJ: Recognition of local anesthetics by αß+ T cells. J Invest Dermatol 1999;112: 197-204.
30. Hausmann S, Wucherpfennig KW: Activation of autoreactive T cells by peptides from human pathogens. Curr Opin Immunol 1997;9:831-838.
31. Mason D: A very high level of cross-reactivity is an essential feature of the T-cell receptor. Immunol Today 1998;19:395-404.
32. Loftus DJ, Chen Y, Covell DG, Engelhard VH, Appella E: Differential contact of disparate class I/peptide complexes as the basis for epitope cross-recognition by a single TCR. J Immunol 1997;158:3651-3658.
33. Garboczi DN, Biddison WE: Shapes of MHC restriction. Immunity 1999;10:1-7.
34. Mauri-Hellweg D, Zanni MP, Frei E, Bettens F, Brander C, Pichler WJ: Cross-reactivity of T cell lines and clones to β-lactam antibiotics. J Immunol 1996;157:1071-1079.
35. Padovan E, Mauri-Hellweg D, Pichler WJ, Weltzien HU: T cell recognition of penicillin G: Structural features determining antigenic specificity. Eur J Immunol 1996;26:41-48.
36. Bircher A, Langauer JS, Surber C, Rufli T: Delayed type hypersensitivity to subcutaneous lidocaine with tolerance of articaine. Confirmation by in vivo and in vitro tests. Contact Dermatitis 1996;34:387-389.
37. Vollmer J, Fritz M, Doromy A, Weltzien HU, Moulon C: Dominance of the BV17 element in nickel-specific human T cell receptors relates to severity of contact sensitivity. Eur J Immunol 1997;27:1865-1874.
38. Hemmer B, Vergelli M, Pinilla C, Houghten R, Martin R: Probing degeneracy in T cell recognition using peptide combinatorial libraries. Immunol Today 1998;19:163-168.
39. Daniel C, Horvath S, Allen PM: A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR. Immunity 1998;8:543-552.
40. Moulon C, Wild D, Dormoy A, Weltzien HU: MHC-dependent and -independent activation of human nickel-specific CD8+cytotoxic cells from allergic donors. J Invest Dermatol 1998; 111:360-366.
41. Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A: Universally immunogenic T cell epitopes: Promiscuous binding to human class II and promiscuous recognition by T cells. Eur J Immunol 1989; 19:2237-2242.
42. Kohler J, Hartmann U, Grimm R, Pflugefelder U, Weltzien HU: Carrier-independent hapten recognition and promiscuous MHC restriction by CD4 T cells induced by trinitrophenylated peptides. J Immunol 1997;158:591-597.
43. Ding YH, Smith KJ, Garboczi DZ, Utz U, Biddison WE, Wiley DC: Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/tax peptide complex using different TCR amino acids. Immunity 1998;8:403-411.
44. Valitutti S, Dessing M, Aktories K, Gallati H, Lanzavecchia A: Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J Exp Med 1995;181:577-584.
45. Viola A, Lanzavecchia A: T cell activation determined by T cell receptor number and tunable thresholds. Science 1996;273:104-106.
46. Hemmer B, Stefanova I, Vergelli M, Germain RN, Martin R: Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. J Immunol 1998; 160:5807-5814.
47. Lanzavecchia A, Reid PA, Watts C: Irreversible association of peptides with class II MHC molecules in living cells. Nature 1992; 357:249-252.
48. Nelson CA, Petzold SJ, Unanue ER: Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 1994;371:250-252.
49. k complexes: Correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci USA 1994;91:12862-12866.